These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2197583)

  • 1. Preoperative immunostimulation with propionibacterium avidum KP-40 in patients with gastric carcinoma: a prospective randomized study.
    Peters KM; Beuth J; Ko HL; Pulverer G; Kluger J; Grundmann R
    Onkologie; 1990 Apr; 13(2):124-7. PubMed ID: 2197583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative nonspecific immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer. A prospective randomized study].
    Grundmann R; Weber F; Kluger J; Wienand P; Pulverer G
    Chirurg; 1988 Apr; 59(4):272-8. PubMed ID: 3289850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of lymphocyte subsets in response to immunotherapy with Propionibacterium avidum KP-40 in cancer patients.
    Beuth J; Ko HL; Peters KM; Bornhofen B; Pulverer G
    Zentralbl Bakteriol; 1990 Aug; 273(3):386-90. PubMed ID: 2206205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment.
    Isenberg J; Stoffel B; Wolters U; Beuth J; Stützer H; Ko HL; Pichlmaier H
    Anticancer Res; 1995; 15(5B):2363-8. PubMed ID: 8572653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neopterin as a marker of aspecific immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors. A prospective randomized study].
    Peters KM; Bornhofen B; Grundmann R; Ko HL; Beuth J; Waters W; Pichlmaier H; Pulverer G
    Med Klin (Munich); 1990 Jul; 85(7):421-4. PubMed ID: 2385207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer.
    Isenberg J; Ko H; Pulverer G; Grundmann R; Stützer H; Pichlmaier H
    Anticancer Res; 1994; 14(3B):1399-404. PubMed ID: 8067712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local immunotherapy of stomach and intestinal carcinoma by Propionibacterium granulosum.
    Gil J; Orlowski T; Nowakowski W; Ko HL; Roszkowski K; Roszkowski W; Szmigielski S; Pulverer G; Jeljaszewicz J
    Dis Colon Rectum; 1980; 23(8):536-43. PubMed ID: 6970114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immunostimulation (Propionibacterium avidum KP 40) and anticoagulation (heparin) prevents metastatic lung and liver colonization in mice.
    Beuth J; Ko HL; Uhlenbruck G; Pulverer G
    J Cancer Res Clin Oncol; 1987; 113(4):359-62. PubMed ID: 3597521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy for non-curatively resected gastric cancer.
    Ishikawa Y; Kakuta H; Fukushima M; Machida S; Fukuda S
    Jpn J Surg; 1979 Sep; 9(3):180-9. PubMed ID: 470250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2.5-year follow-up of local immunotherapy of advanced stomach and intestinal adenocarcinoma with Propionibacterium granulosum.
    Gil J; Badowski A; Orlowski T; Szmigielski S; Ko HL; Jeljaszewicz J; Pulverer G
    J Cancer Res Clin Oncol; 1983; 105(1):98-102. PubMed ID: 6833344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of spleen preservation in patients with gastric cancer.
    Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
    Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer.
    Fujitani K; Tsujinaka T; Fujita J; Miyashiro I; Imamura H; Kimura Y; Kobayashi K; Kurokawa Y; Shimokawa T; Furukawa H;
    Br J Surg; 2012 May; 99(5):621-9. PubMed ID: 22367794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
    Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
    Ichihashi H; Kondo T; Nakazato H
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
    Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
    Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
    Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
    World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.